Mission Statement
Frontiers transcends disciplines to seek innovation and improvement in healthcare by supporting the researchers of today and tomorrow.
At a Glance
0
Educational Resources Posted
4
Consortium News Stories Posted
1
Events Posted
1
Opportunities Posted
Coming Soon
Publications citing CTSA Program Grant
20
Users from Hub Registered
Website
Contact PI Organization
University of Kansas Medical Center
Programs
UL1 Award
KL2 Award
TL1 Award
Funded Years
2013 – 2015, 2017 – 2020
Networks
- Vasculitis Clinical Research Consortium (VCRC)
Visit VCRC Website - Clinical Research in ALS and Related Disorders for Therapeutic Development (CReATe)
Visit CReATe Website - Midwest Consortium
- Greater Plains Collaborative Clinical Data Research Networkhttp://www.gpcnetwork.org/
- Consortium of Rural States
Page Administrators
Jennifer Baker
Administrative Director
University of Kansas Medical Center
UL1
UL1 Administrator
Jennifer Baker
Administrative Director
University of Kansas Medical Center
Education
KL2 Director
Edward. Ellerbeck
Professor
University of Kansas Medical Center
KL2 Administrator
Amy Smith
University of Kansas Medical Center
TL1 Director
Won Choi
Professor and Director of TL1 Program
University of Kansas Medical Center
TL1 Administrator
Amy Smith
University of Kansas Medical Center
Communications
Communications Representative
Marion During
Communication Specialist
University of Kansas Medical Center
Enterprise Committees
Integration Across Lifespan Voting Member
J Steven Leeder
Deputy Director, Children’s Research Institute
Other
Common Metrics
Primary CM Contact
Maria Hondras
University of Kansas Medical Center
Additional CM Contacts
william brooks
associate director
University of Kansas Medical Center
- Jennifer Baker
Administrative Director
University of Kansas Medical Center - Amanda Brinker
Deputy Director for The Institute for Advancing Medical Innovation
University of Kansas Medical Center - william brooks
associate director
University of Kansas Medical Center - Mario Castro
Director, Frontiers: University of Kansas Clinical and Translational Science Institute
University of Kansas Medical Center - Won Choi
Professor and Director of TL1 Program
University of Kansas Medical Center - Marion During
Communication Specialist
University of Kansas Medical Center - Edward Ellerbeck
Professor
University of Kansas Medical Center - Mary Hindle
Division Director, Research Communications & Education
University of Kansas Medical Center - Maria Hondras
University of Kansas Medical Center - Kim Kimminau
Professor and Associate Director, Frontiers: University of Kansas Clinical and Translational Science Institute
University of Kansas Medical Center - Robin Liston
Assistant Administrative Director
University of Kansas Medical Center - Mei Liu
Assistant Professor
University of Kansas Medical Center - Dawn Lockhart
Recruitment and Trial Innovation Unit Navigator
University of Kansas Medical Center - Maren Lowrance
University of Kansas Medical Center - Elizabeth Ruelas
Administrative Assistant
University of Kansas Medical Center - Amy Smith
University of Kansas Medical Center - Ruth Sosnoff
Executive Director, Frontiers
University of Kansas Medical Center - Jennifer Staley
Director, Clinical Research Administration
University of Kansas Medical Center - Russ Waitman
Professor
University of Kansas Medical Center - Tamara Winden
CRIO
University of Kansas Medical Center
Events
View All Events
Radical Changes in Healthcare Delivery Due to COVID-19: a KC QVIC Forum
The Kansas City Quality and Value Innovation Consortium (KC QVIC) is hosting an online forum on Thursday, June 4, for healthcare leaders from across the metro to discuss how healthcare has changed due to the COVID-19 pandemic.
Opportunities
View All Opportunities
Frontiers Project Manager
Frontiers: University of Kansas Clinical and Translational Science Institute is looking for a Project Manager to help organize and submit our renewal application and become an integral part of the team. This person will work with a senior team of researchers and clinicians and will be responsible
Posters
View All Posters
Conducting a COVID-19 Vaccine Trial Using CTSA Resources: Lessons Learned
AZD1222 is being developed for the prevention of COVID-19. AZD1222 is a recombinant replication-defective chimpanzee adenovirus expressing the SARS-CoV-2 S surface glycoprotein, commonly known as the “Oxford vaccine” or as “ChAdOx.” We describe a “scale up” approach utilizing CTSA resources to
The Institute for Advancing Medical Innovation: From Bench-to-Bedside and Back Again
A Blue Ribbon taskforce convened in 2005 concluded that in order to effectively advance medical care in a region, “a strong translational research enterprise needed to be developed which could take basic discoveries from the laboratories, translate them into drugs and therapeutic devices, manage